Company Filing History:
2 out of 102 
1 out of 964 
1 out of 34 
Years Active: 2017-2021
Title: Nitza Lahat: Innovator in Extracellular Matrix Research
Introduction
Nitza Lahat is a prominent inventor based in Atlit, Israel. She has made significant contributions to the field of biomedical research, particularly in the development of innovative peptides and antibodies. With a total of 2 patents, her work focuses on addressing critical health issues through advanced therapeutic methods.
Latest Patents
Nitza Lahat's latest patents include the invention of extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies. This invention provides isolated peptides derived from the protein EMMPRIN (CD147/Basigin) and antibodies that target specific antigenic determinants within these peptides. The pharmaceutical compositions that incorporate these peptides and antibodies are designed for use in vaccination, immunotherapy, and the diagnosis of various diseases and disorders related to proliferation, hyperpermeability, inflammation, and angiogenesis.
Career Highlights
Throughout her career, Nitza has worked with notable organizations such as Mor Research Applications Ltd. and Technion Research & Development Foundation Limited. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Nitza has collaborated with esteemed colleagues, including Michal A Rahat and Miriam Walter. These partnerships have fostered a collaborative environment that enhances the impact of her research.
Conclusion
Nitza Lahat's innovative work in the field of extracellular matrix research exemplifies her commitment to advancing medical science. Her patents and collaborations reflect her dedication to improving health outcomes through targeted therapies.